EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Increased PRP19 in Hepatocyte Impedes B Cell Function to Promote Hepatocarcinogenesis

Zhiyong Liu, Xiahui Lin, Danying Zhang, Dezhen Guo, Wenqing Tang, Xiangnan Yu, Feng Zhang, Si Zhang, Ruyi Xue, Xizhong Shen, Ling Dong iD

Advanced Science · 2024

DOI: 10.1002/advs.202407517 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Science, 2024. Verfasst von Zhiyong Liu und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology and Hepatology, Shanghai Institute of Liver Disease, Zhongshan Hospital, Fudan University, Shanghai, 200030, China. Hauptthemen laut MEDLINE: Liver Neoplasms, Carcinoma, Hepatocellular, B-Lymphocytes. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 68 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Shanghai Science and Technology Committee, Science and Technology Commission of Shanghai Municipality.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Tumor immune microenvironment is strongly associated with the malignancy behavior of hepatocellular carcinoma (HCC). However, the immune function and regulatory mechanisms of B cells in HCC remain unclear. The expression differences between B cell high‐ and low‐infiltration HCC samples are explored to identify the key regulator. Pre‐mRNA processing factor 19 (PRP19) expression is increased in B cell low‐infiltrated tissues and negatively correlated with the B cell marker, CD20. Inhibition of PRP19 expression promoted B cell infiltration in tumor tissue and impeded HCC growth. Mechanically, the co‐immunoprecipitation (Co‐IP) assay revealed that PRP19 interacts with DEAD‐box helicase 5 (DDX5), leading to ubiquitination and degradation of the DDX5 protein. The attenuated DDX5 impairs CXCL12 mRNA stability to suppress B cell recruitment and plasma cell differentiation via CXCL12/CXCR4 axis. Moreover, the adoptive transfer of CXCR4+ B cells combined with CXCL12 treatment in mice models effectively inhibits HCC development by reshaping the immune response. The expression of PRP19, DDX5, and infiltrating B cells are recognized as clinical prognosis indicators for HCC patients. Overall, this study provides valuable insights into the clinical benefits of HCC immunotherapy by targeting PRP19 and modulating tumor‐infiltrating B cell immune function.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Liver NeoplasmsCarcinoma, HepatocellularB-LymphocytesAnimalsMiceHumansHepatocytesTumor MicroenvironmentDisease Models, AnimalRNA Splicing FactorsCarcinogenesisChemokine CXCL12Male

Stichwörter der Autor:innen

Pre‐mRNA processing factor 19hepatocellular carcinomaimmune responsetumor microenvironmenttumor‐infiltrating B cells

Substanzen

RNA Splicing FactorsChemokine CXCL12

Autor:innen und Institutionen

  • Department of Gastroenterology and Hepatology, Shanghai Institute of Liver Disease, Zhongshan Hospital, Fudan University, Shanghai, 200030, China.
  • Department of Liver Surgery, Zhongshan Hospital, Fudan University, Shanghai, 200030, China.
  • NHC Key Laboratory of Glycoconjugate Research, Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Fudan University, Shanghai, 200030, China.

ORCID-Profile: Ling Dong

Förderung

  • National Natural Science Foundation of China
  • Shanghai Science and Technology Committee
  • Science and Technology Commission of Shanghai Municipality

Zitieren

APA

Liu, Z., Lin, X., Zhang, D., Guo, D., Tang, W., Yu, X., Zhang, F., Zhang, S., Xue, R., Shen, X., & Dong, L. (2024). Increased PRP19 in Hepatocyte Impedes B Cell Function to Promote Hepatocarcinogenesis. Advanced Science. https://doi.org/10.1002/advs.202407517

Vancouver

Liu Z, Lin X, Zhang D, Guo D, Tang W, Yu X, et al. Increased PRP19 in Hepatocyte Impedes B Cell Function to Promote Hepatocarcinogenesis. Advanced Science. 2024. doi:10.1002/advs.202407517

BibTeX
@article{Liu2024,
  author = {Liu, Zhiyong and Lin, Xiahui and Zhang, Danying and Guo, Dezhen and Tang, Wenqing and Yu, Xiangnan and Zhang, Feng and Zhang, Si and Xue, Ruyi and Shen, Xizhong and Dong, Ling},
  title = {Increased PRP19 in Hepatocyte Impedes B Cell Function to Promote Hepatocarcinogenesis},
  journal = {Advanced Science},
  year = {2024},
  doi = {10.1002/advs.202407517}
}
Kostenlos starten →